Fosun Pharma (02196) Completes Issuance of First Tranche of 2026 Scientific and Technological Innovation Bonds

Bulletin Express

02/03

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (Stock Code: 02196) recently completed the issuance of its first tranche of 2026 scientific and technological innovation bonds under a RMB4 billion registered program. The new bonds have a total principal of RMB1 billion, a two-year term, and a coupon rate of 2.4%. The value date is set at 2 February 2026, with a payment date of 2 February 2028.

China Merchants Bank Co., Ltd. acted as the leading underwriter, with Bank of Beijing Co., Ltd., Shanghai Pudong Development Bank Co., Ltd., China Everbright Bank Company Limited, and HUA XIA BANK CO., Limited serving as joint leading underwriters. Relevant issuance documents are available on the websites of China Money and the Shanghai Clearing House.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1129734524"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1129734524\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1129734524?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-03 18:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1129734524","market":"hk","top_or_hot":-1,"title":"Fosun Pharma (02196) Completes Issuance of First Tranche of 2026 Scientific and Technological Innovation Bonds","media":"Bulletin Express","content":"<p>Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (Stock Code: 02196) recently completed the issuance of its first tranche of 2026 scientific and technological innovation bonds under a RMB4 billion registered program. The new bonds have a total principal of RMB1 billion, a two-year term, and a coupon rate of 2.4%. The value date is set at 2 February 2026, with a payment date of 2 February 2028.</p>\n<p>China Merchants Bank Co., Ltd. acted as the leading underwriter, with Bank of Beijing Co., Ltd., Shanghai Pudong Development Bank Co., Ltd., China Everbright Bank Company Limited, and HUA XIA BANK CO., Limited serving as joint leading underwriters. Relevant issuance documents are available on the websites of China Money and the Shanghai Clearing House.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Fosun Pharma (02196) Completes Issuance of First Tranche of 2026 Scientific and Technological Innovation Bonds</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFosun Pharma (02196) Completes Issuance of First Tranche of 2026 Scientific and Technological Innovation Bonds\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time smaller\">2026-02-03 18:24</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (Stock Code: 02196) recently completed the issuance of its first tranche of 2026 scientific and technological innovation bonds under a RMB4 billion registered program. The new bonds have a total principal of RMB1 billion, a two-year term, and a coupon rate of 2.4%. The value date is set at 2 February 2026, with a payment date of 2 February 2028.</p>\n<p>China Merchants Bank Co., Ltd. acted as the leading underwriter, with Bank of Beijing Co., Ltd., Shanghai Pudong Development Bank Co., Ltd., China Everbright Bank Company Limited, and HUA XIA BANK CO., Limited serving as joint leading underwriters. Relevant issuance documents are available on the websites of China Money and the Shanghai Clearing House.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02196","symbol_name":"復星醫藥","start_time":0,"source_url":"","article_id":"1129734524","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1129734524","pubTimestamp":1770114240,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (Stock Code: 02196) recently completed the issuance of its first tranche of 2026 scientific and technological innovation bonds under a RMB4 billion...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02196":"复星医药"},"translate_title":"复星医药(02196)完成2026年度第一期科创债发行","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02196":1},"content_text":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (Stock Code: 02196) recently completed the issuance of its first tranche of 2026 scientific and technological innovation bonds under a RMB4 billion registered program. The new bonds have a total principal of RMB1 billion, a two-year term, and a coupon rate of 2.4%. The value date is set at 2 February 2026, with a payment date of 2 February 2028.\nChina Merchants Bank Co., Ltd. acted as the leading underwriter, with Bank of Beijing Co., Ltd., Shanghai Pudong Development Bank Co., Ltd., China Everbright Bank Company Limited, and HUA XIA BANK CO., Limited serving as joint leading underwriters. Relevant issuance documents are available on the websites of China Money and the Shanghai Clearing House.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}